EUVIMEDEUVIMED entdecken
Crossref

Dapagliflozin Interrupts Pro‐Fibroinflammatory Interleukin 11‐Tenascin C Mutual Reinforcement in Fibroblasts by Antagonizing Interleukin‐11 Receptor Subunit Alpha

Yen-Chen Lin iD, Wei-Jan Chen, Yu-Juei Hsu, Ying-Ju Lai, Cheng-Chin Kuo, Yung-Hsin Yeh iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Yen-Chen Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Fibroblasts, Interleukin-11, Glucosides, Benzhydryl Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: This study is supported by Chang Gung Medical Foundation grant CMRP program with Assistance Agreement CMRPG3N0301, CMRPG3N0302 and CMRPG3P0511..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium/glucose cotransporter 2 inhibitors (SGLT2i) protect against heart failure and fibroinflammation with an unclear mechanistic. Recombinant interleukin‐11 (IL11) therapy for thrombocytopenia induces heart failure symptoms and signs. Profibrotic IL11 upregulates extracellular matrix (ECM) proteins, whereas pro‐inflammatory tenascin‐C (TNC) is an ECM‐derived alarmin. We hypothesized IL11 upregulated TNC to induce fibroinflammation via Toll‐like receptor 4 (TLR4) and prototype SGLT2i dapagliflozin counteracted the effects. We stimulated fibroblasts with IL11 and confirmed TNC upregulation. NADPH oxidase 2 (NOX2) is known to participate in TNC‐TLR4 signaling. We treated IL11‐stimulated fibroblasts with inhibitors of TLR4 (TLR4i) and NOX2 (NOX2i) and found IL11 induced an imperative profibrotic TNC‐TLR4‐NOX2 auto‐amplification loop. IL11 is known to induce ERK‐dependent positive autofeedback. By finding TLR4i and NOX2i inhibited IL11‐induced ERK phosphorylation, we suspected IL11‐ERK joined TNC‐TLR4‐NOX2 auto‐amplification fibroinflammatory pathway. We stimulated fibroblasts with TNC and found IL11 upregulation. We treated TNC‐stimulated fibroblasts with TLR4i, NOX2i, or neutralizing IL11 antibody and confirmed TLR4‐NOX2 and IL11 were indispensable for TNC‐induced fibrosis. We concluded that IL11‐ERK, TNC‐TLR4, and NOX2 are interdependent in fibroblasts and together make a positive‐feedback loop to sustain fibroinflammation. We checked mRNA expression of relevant proteins from proteinatlas.org and found fibroblasts are overwhelming producers of IL11 and TNC in the heart. IL11 receptor subunit alpha (IL11RA) and TLR4 are highly differentially expressed with the former on cardiomyocytes and the latter on macrophages. We therefore proposed a model of differentially activated IL11RA and TLR4 signaling in response to mutually reinforcing IL11‐TNC alarmins, to explain how activated fibroblasts pivotally support fibroinflammatory microenvironment and how danger signals induce cell‐type‐specific responses. Next, we showed dapagliflozin prevented fibroinflammation induced by IL11 or TNC. Mechanistically, we showed dapagliflozin antagonized IL11RA by molecular docking, fluorescence quenching, and grading‐dose IL11‐signaling inhibitor cocktails studies. In conclusion, dapagliflozin interrupts pro‐fibroinflammatory IL11‐TNC bi‐alarmin mutual reinforcement in human cardiac fibroblasts by antagonizing IL11RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsInterleukin-11GlucosidesBenzhydryl CompoundsTenascinInterleukin-11 Receptor alpha SubunitInflammationToll-Like Receptor 4HumansFibrosisAnimalsSignal TransductionNADPH Oxidase 2Sodium-Glucose Transporter 2 InhibitorsMice

Stichwörter der Autor:innen

NADPH oxidaseSGLT2 inhibitorToll‐like receptor 4fibrosisinflammationinterleukin‐11tenascin C

Substanzen

Interleukin-11GlucosidesToll-Like Receptor 4dapagliflozinBenzhydryl CompoundsTenascinInterleukin-11 Receptor alpha SubunitNADPH Oxidase 2Sodium-Glucose Transporter 2 InhibitorsTLR4 protein, human

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.
  • Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
  • Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

ORCID-Profile: Yen-Chen Lin, Yung-Hsin Yeh

Förderung

  • This study is supported by Chang Gung Medical Foundation grant CMRP program with Assistance Agreement CMRPG3N0301, CMRPG3N0302 and CMRPG3P0511.

Zitieren

APA

Lin, Y. C., Chen, W. J., Hsu, Y. J., Lai, Y. J., Kuo, C. C., & Yeh, Y. H. (2025). Dapagliflozin Interrupts Pro‐Fibroinflammatory Interleukin 11‐Tenascin C Mutual Reinforcement in Fibroblasts by Antagonizing Interleukin‐11 Receptor Subunit Alpha. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70052

Vancouver

Lin YC, Chen WJ, Hsu YJ, Lai YJ, Kuo CC, Yeh YH. Dapagliflozin Interrupts Pro‐Fibroinflammatory Interleukin 11‐Tenascin C Mutual Reinforcement in Fibroblasts by Antagonizing Interleukin‐11 Receptor Subunit Alpha. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70052

BibTeX
@article{Lin2025,
  author = {Lin, Yen-Chen and Chen, Wei-Jan and Hsu, Yu-Juei and Lai, Ying-Ju and Kuo, Cheng-Chin and Yeh, Yung-Hsin},
  title = {Dapagliflozin Interrupts Pro‐Fibroinflammatory Interleukin 11‐Tenascin C Mutual Reinforcement in Fibroblasts by Antagonizing Interleukin‐11 Receptor Subunit Alpha},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70052}
}
Kostenlos starten →